newsfilter
← Latest News
ACCESS Newswire·

Biophytis Announces Receipt of Nasdaq Notice

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 17, 2023 / Biophytis SA , , a clinical-stage biotechnology company specialized in the